Since our previous results indicated that treatment with P60 reduces the development of lung metastases in experimental BRCA [22], we evaluated whether Foxp3 affects the migratory capacity of LM3 cells using the wound assay. The gene discussed is FOXP3; the disease is invasive breast carcinoma.